PubMed for id: 32700008

Year	Number of Results
2003	2
2004	3
2005	2
2006	1
2007	4
2008	4
2009	1
2010	2
2011	2
2012	1
2013	1
2021	1
2024	0

1

Convergence of mammalian RQC and C-end rule proteolytic pathways via alanine tailing.

Thrun A, Garzia A, Kigoshi-Tansho Y, Patil PR, Umbaugh CS, Dallinger T, Liu J, Kreger S, Patrizi A, Cox GA, Tuschl T, Joazeiro CAP. Thrun A, et al. Mol Cell. 2021 May 20;81(10):2112-2122.e7. doi: 10.1016/j.molcel.2021.03.004. Epub 2021 Apr 27. Mol Cell. 2021. PMID: 33909987 Free PMC article.

2

Toward a comprehensive characterization of a human cancer cell phosphoproteome.

Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, Mohammed S. Zhou H, et al. J Proteome Res. 2013 Jan 4;12(1):260-71. doi: 10.1021/pr300630k. Epub 2012 Dec 18. J Proteome Res. 2013. PMID: 23186163

3

Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.

Wu H, Zeinab RA, Flores ER, Leng RP. Wu H, et al. Mol Cancer Res. 2011 Dec;9(12):1780-90. doi: 10.1158/1541-7786.MCR-11-0157. Epub 2011 Oct 12. Mol Cancer Res. 2011. PMID: 21994467

4

Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis.

Jung YS, Hakem A, Hakem R, Chen X. Jung YS, et al. Mol Cell Biol. 2011 Oct;31(19):3997-4006. doi: 10.1128/MCB.05808-11. Epub 2011 Jul 26. Mol Cell Biol. 2011. PMID: 21791603 Free PMC article.

5

A novel hPirh2 splicing variant without ubiquitin protein ligase activity interacts with p53 and is down-regulated in hepatocellular carcinoma.

Wu G, Sun M, Zhang L, Zhou J, Wang Y, Huo K. Wu G, et al. FEBS Lett. 2010 Jul 2;584(13):2772-8. doi: 10.1016/j.febslet.2010.04.075. Epub 2010 May 7. FEBS Lett. 2010. PMID: 20452352 Free article.

6

Identification of Pirh2D, an Additional Novel Isoform of Pirh2 Ubiquitin Ligase.

Shi J, Huang Y, Sheikh MS. Shi J, et al. Mol Cell Pharmacol. 2010;2(1):21-23. doi: 10.4255/mcpharmacol.10.04. Mol Cell Pharmacol. 2010. PMID: 20357911 Free PMC article.

7

Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.

Corcoran CA, Montalbano J, Sun H, He Q, Huang Y, Sheikh MS. Corcoran CA, et al. J Biol Chem. 2009 Aug 14;284(33):21955-21970. doi: 10.1074/jbc.M109.024232. Epub 2009 May 29. J Biol Chem. 2009. PMID: 19483087 Free PMC article.

8

Molecular basis of Pirh2-mediated p53 ubiquitylation.

Sheng Y, Laister RC, Lemak A, Wu B, Tai E, Duan S, Lukin J, Sunnerhagen M, Srisailam S, Karra M, Benchimol S, Arrowsmith CH. Sheng Y, et al. Nat Struct Mol Biol. 2008 Dec;15(12):1334-42. doi: 10.1038/nsmb.1521. Epub 2008 Nov 30. Nat Struct Mol Biol. 2008. PMID: 19043414 Free PMC article.

9

A quantitative atlas of mitotic phosphorylation.

Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. Dephoure N, et al. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. Proc Natl Acad Sci U S A. 2008. PMID: 18669648 Free PMC article.

10

Phosphoproteome of resting human platelets.

Zahedi RP, Lewandrowski U, Wiesner J, Wortelkamp S, Moebius J, Schütz C, Walter U, Gambaryan S, Sickmann A. Zahedi RP, et al. J Proteome Res. 2008 Feb;7(2):526-34. doi: 10.1021/pr0704130. Epub 2007 Dec 19. J Proteome Res. 2008. PMID: 18088087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year